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Abstract
In this paper, digital quantitative detection of nucleic acids was achieved at the single-molecule
level by chemical initiation of over one thousand sequence-specific, nanoliter, isothermal
amplification reactions in parallel. Digital polymerase chain reaction (digital PCR), a method used
for quantification of nucleic acids, counts the presence or absence of amplification of individual
molecules. However it still requires temperature cycling, which is undesirable under resource-
limited conditions. This makes isothermal methods for nucleic acid amplification, such as
recombinase polymerase amplification (RPA), more attractive. A microfluidic digital RPA
SlipChip is described here for simultaneous initiation of over one thousand nL-scale RPA
reactions by adding a chemical initiator to each reaction compartment with a simple slipping step
after instrument-free pipette loading. Two designs of the SlipChip, two-step slipping and one-step
slipping, were validated using digital RPA. By using the digital RPA SlipChip, false positive
results from pre-initiation of the RPA amplification reaction before incubation were eliminated.
End-point fluorescence readout was used for “yes or no” digital quantification. The performance
of digital RPA in a SlipChip was validated by amplifying and counting single molecules of the
target nucleic acid, Methicillin-resistant Staphylococcus aureus (MRSA) genomic DNA. The
digital RPA on SlipChip was also tolerant to fluctuations of the incubation temperature (37–42
°C), and its performance was comparable to digital PCR on the same SlipChip design. The digital
RPA SlipChip provides a simple method to quantify nucleic acids without requiring thermal
cycling or kinetic measurements, with potential applications in diagnostics and environmental
monitoring under resource-limited settings. The ability to initiate thousands of chemical reactions
in parallel on the nanoliter scale using solvent-resistant glass devices is likely to be useful for a
broader range of applications.
Introduction
This paper demonstrates a SlipChip for highly parallel chemical initiation of reactions,
validated by performing digital isothermal quantification of nucleic acids in a sequence-
specific manner by using recombinase polymerase amplification (RPA). Quantitative
analysis of nucleic acids is important for studying gene expression1 and molecular
diagnostics, such as for detection of pathogens,2–4 analysis of genomic diseases and
r-ismagilov@uchicago.edu.
Supporting Information Available: Chemicals and materials, detailed experimental procedures and additional figures. This material is
available free of charge via http://pubs.acs.org.
NIH Public Access
Author Manuscript
Anal Chem. Author manuscript; available in PMC 2012 May 1.
Published in final edited form as:
Anal Chem. 2011 May 1; 83(9): 3533–3540. doi:10.1021/ac200247e.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
cancer,5,6 monitoring of viral load,7–9 and prenatal diagnostics.10,11 For quantitative nucleic
acid analysis methods to be used at the point-of-care (POC) such as in resource-limited
settings or in-home medicine, they must be simple, inexpensive, and easy to use. The most
widely used method for nucleic acid amplification and quantitative analysis is real-time
polymerase chain reaction (PCR)12 and real-time reverse-transcription polymerase chain
reaction (RT-PCR).13 Real-time methods are based on the detection of an exponential
increase of fluorescence intensity and rapid thermal cycling between the dissociation
temperature (~95°C), annealing temperature (~50°C), and synthesis temperature (~70°C).
Digital PCR is another method for quantitative analysis of nucleic acids.5,14,15 By dividing
the diluted sample into a large number of small-volume reaction compartments, single
copies of nucleic acid template can be confined in isolated compartments and amplified by
PCR. Only a “yes or no” readout is required, and the number of target molecules in the
sample is determined by performing a statistical analysis on the number of “positive” and
“negative” wells. This method transfers the exponential amplification profile into a linear,
digital format. Digital PCR can be performed in a variety of formats, including well plates,5
microdroplets,16–18 pneumatic controlled microchips,19 spinning discs,20 OpenArray,21 and
the SlipChip.22 Although some of these methods have considerably simplified the process of
generating a large number of individual, small-volume reaction compartments, an essential
step for digital amplification, these digital PCR methods still require thermal cycling and
accurate temperature control.
To avoid thermal cycling, different isothermal amplification methods have been developed,
such as loop-mediated amplification (LAMP),23 nucleic acid sequence based amplification
(NASBA),24 recombinase polymerase amplification (RPA),25 rolling circle amplification
(RCA),26 helicase-dependent amplification (HDA),27 transcription-mediated amplification
(TMA),28,29 multiple displacement amplification (MDA),30 and strand-displacement
amplification (SDA).31,32 RCA has been demonstrated in a digital format by using a droplet-
based microfluidic platform to amplify a bacterial plasmid,33 but this method still requires a
fluidic pump to accurately control the fluidic flow in order to generate uniform droplets and
RCA only works with a circular nucleic acid template. Moreover, the preparation step before
incubation was done on ice to avoid pre-amplification, since RCA is generally performed at
30°C. Digital MDA was also developed to quantify nucleic acid contamination independent
of sequence.34 However, this method cannot be used to detect and quantify a specific gene
sequence, which is desirable for molecular diagnostics. In addition, pre-amplification is still
a potential problem for this digital MDA platform. LAMP has been incorporated on a
microchip and a micro-chamber,35 but it still requires a heating mechanism to maintain the
reaction temperature at 63°C, which may not be ideal for a point-of-care device in resource-
limited settings. NASBA and RPA have also been integrated on a microchip platform with a
real-time fluorescence imaging system or an absorbance measurement system for
quantitative analysis.36–38 However, these real-time methods of isothermal amplification are
sensitive to temperature because the enzyme activity is highly temperature-dependent. To
avoid effects of temperature changes and fluctuations, calibration must be done in parallel to
quantitatively analyze nucleic acids. Moreover, most of the methods for detection and
analysis of nucleic acids using NASBA and RPA still depend on interpreting exponential
amplification profiles.
Although digital PCR requires thermal cycling and accurate temperature control, it is
straightforward because initiation of the amplification reaction is controlled by temperature.
Special “hot-start” modifications of PCR polymerases are now widely used and essentially
eliminate any low-temperature non-specific pre-amplification.39 Therefore, the PCR
reaction mixture can be compartmentalized prior to initiation with minimal risk of false-
positives due to pre-initiation. In situations where the infrastructure for thermal cycling is
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readily available, digital PCR is an attractive option for nucleic acid quantification. In
limited-resource or point-of-care settings, digital isothermal amplification methods that take
place at temperatures near room temperature (such as RPA) are advantageous because they
do not rely on temperature for initiation, but rather rely on chemistry. However, if the
nucleic acid target is premixed with the initiation reagent prior to compartmentalization, one
would expect the amplification reaction to proceed even at room temperature and thus
increase the target count. Therefore, to perform digital isothermal nucleic acid amplification,
one needs to compartmentalize the sample containing the nucleic acid target prior to adding
the initiation reagents. In principle, this multistep manipulation is doable with valves40,41
and droplets,33,42–46 but would require complex control systems and instrumentation, so in
our opinion, it could be most simply achieved on a SlipChip.
The SlipChip is a microfluidic platform that enables such multistep manipulation of large
numbers of small volumes in parallel.47,48 The SlipChip has been used to perform protein
crystallization,49,50 immunoassays,48 multiplex PCR,51 and digital PCR.22 The SlipChip
consists of two plates containing wells and ducts that can be brought in contact and moved
relative to one another to manipulate fluids by creating and breaking fluidic paths. The
pattern of wells and ducts in the two plates can contain almost any program to manipulate
fluid volumes; compartmentalizing a sample into many small volumes and mixing each
small volume with a reagent can be performed by simple subsequent slipping of the two
plates.
In this paper, we describe a SlipChip to perform digital isothermal amplification by using
RPA. We have demonstrated that digital RPA did not require precise temperature control, as
we obtained equivalent quantification results when quantifying MRSA gDNA at 37°C,
39°C, and 42°C. The technical advance illustrated here is the capability to first confine
individual target molecules into separate reaction compartments, and then deliver chemical
initiators to initiate all reactions in parallel, a requirement of digital RPA. This SlipChip can
also be applied to perform other high throughput chemical reactions or screenings which
require multistep processes such as confinement of one reagent and then addition of
subsequent reagents in sequence.
Results and Discussion
The mechanism of DNA amplification and fluorescence signal generation facilitated by
RPA is described in greater detail elsewhere.25 Briefly, RPA uses nucleoprotein complexes
consisting of oligonucleotide primers and recombinase proteins to target binding sites within
template DNA. Upon their binding, the primers are extended by strand-displacing
polymerases, thereby copying the target sequence. The use of primers binding to the
opposing strands of the template initiates a process of exponential DNA amplification. The
generation of amplified target material can be monitored by an appropriate oligonucleotide-
probe based fluorescence detection system. In the approach used here, a fluorophore/
quencher bearing probe is nucleolytically cut in response to sequence-specific binding to
amplified DNA. This processing step results in a separation of the fluorophore and quencher
groups, thereby leading to an increase in observable fluorescence.
Although the RPA reaction normally proceeds at 39°C, we first tested whether it would
proceed even at room temperature (25°C) upon mixing of the reagents in well plates,
therefore potentially affecting the accuracy of the RPA results when performed in a digital
format. The RPA solution was mixed with magnesium acetate and Methicillin-resistant
Staphylococcus aureus (MRSA) genomic DNA (gDNA, final concentration of 5 pg/μL),
then immediately placed in the plate reader (temperature controlled at 25 °C). The
fluorescence intensity from wells containing gDNA template (Figure 1, green) started
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increasing within 20 min, which was significantly different from the fluorescent intensity of
the control well without magnesium acetate (Figure 1, blue) and the control well without
gDNA template (Figure 1, orange).
This result indicated that the RPA reaction amplified the target nucleic acid template in the
presence of magnesium acetate at room temperature. Therefore, to achieve digital RPA
without false-positive errors, the nucleic acid template must be compartmentalized first and
then magnesium acetate should be added to each individual compartment. The non-initiating
components of the RPA reaction mixture (RPA enzymes, buffer, primers, and probe) can be
added to the solution containing nucleic acid template, to the solution of magnesium acetate,
or to both.
To achieve this goal, we designed a SlipChip with two-step slipping that was able to load
and compartmentalize two different reagents that could be combined by slipping (Figure 2).
Each plate of the RPA SlipChip was designed to contain 800 wells of Type I (6 nL) and 800
wells of Type II (3 nL). Each Type II well also had two satellite wells (0.2 nL) to address
potential thermal expansion51 during the temperature change from room temperature to 39
°C. The satellite wells provided additional space for thermal expansion of the aqueous
reagent within the compartment formed by overlapping the Type I and Type II wells. A total
of 1,550 reaction compartments (9 nL each) were formed by overlapping the Type I and
Type II wells contained in the facing plates (Figure 2F, I, N). The SlipChip also contained
50 wells for control 1 (Type I wells, 6 nL, Figure 2A, F, J) and 50 wells for control 2 (Type
II wells, 3 nL, Figure 2A, F, H).
The digital RPA SlipChip was assembled by combining the top plate (Figure 2A) and
bottom plate (Figure 2B) with a thin layer of tetradecane between as the lubricating fluid.
The lubricating fluid prevented cross-contamination and evaporation of the aqueous sample
during incubation. The first continuous fluidic path was formed by overlapping the Type I
wells in the two plates (Figure 2C). RPA Reaction Mixture 1, containing RPA primers and
probe, MRSA gDNA, and re-hydrated RPA enzyme mixture, but no magnesium acetate,
was loaded by pipetting (Figure 2D, K). This RPA SlipChip device was designed to be filled
via dead-end filling, therefore, the speed of sample injection does not have to be controlled
accurately as long as the applied pressure is lower than the leaking pressure.52 The two
plates were then slipped relative to one another to compartmentalize RPA Reaction Mixture
1, simultaneously stochastically confining the gDNA template in the Type I wells and
forming the second fluidic path by overlapping the Type II wells (Figure 2E, L). RPA
Reaction Mixture 2, which contained no gDNA and contained magnesium acetate at three
fold higher concentration than required for the bulk reaction (3X, so the final concentration
of magnesium acetate after mixing would be 1X), RPA primers and probe, and re-hydrated
RPA enzyme, was also loaded into the chip by pipetting (Figure 2E, M). Finally, the two
plates were slipped relative to one another to overlap the Type I wells with the Type II wells
in the facing plates, delivering the magnesium acetate in Reaction Mixture 2 to all 1550 of
the Type I wells simultaneously and initiating the reaction (Figure 2F, N; Figure S1 in the
Supporting Information shows loading of the digital RPA SlipChip with food dyes). The
digital RPA SlipChip was then placed on a flat metal adapter and incubated at 39 °C for 1
hour. Type I wells for Control 1 contained only Reaction Mixture 1 (negative control, no
magnesium acetate), and Type II wells for Control 2 contained only Reaction Mixture 2
(negative control, no nucleic acid template).
We first tested the digital RPA SlipChip with a sample containing a 1:104 dilution of 5 ng/
μL of stock MRSA gDNA. The stock gDNA was purified from MRSA culture (see
Experimental Section in Supporting Information), and the optical density of the purified
nucleic acid product was measured spectrophotometrically. At this concentration, the
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average copy number of gDNA per well was expected to be less than 1, and single-copy
RPA was achieved. The reaction solution of RPA was made from rehydrating the
lyophilized reagent (see Experimental Section in Supporting Information), and was
heterogeneous: microparticles of various sizes and shapes were still present even after
sonication and vortexing the solution (Figure 3A, see Experimental Section in Supporting
Information). A linescan of the fluorescence intensity of wells from the digital RPA
SlipChip before and after incubation at 39°C (Figure 3) shows that the fluorescence intensity
of a positive well increased significantly compared to a negative well (Figure 3A–B) and the
control wells (Figure 3C–F) after incubation for one hour. The number and the size of
microparticles decreased after incubation, which was probably due to further dissolution of
the microparticles during incubation at 39°C. There was no significant increase of
fluorescence intensity from control wells without magnesium acetate (representative Control
well 1, Figure 3C–D) and without gDNA template (representative Control well 2, Figure
3E–F). Only the endpoint fluorescent intensity was monitored in this experiment. As
demonstrated in previous work,25 the amplification signal may be observed in less than 30
min. A real-time fluorescence detector would be useful to further investigate the uniformity
of amplification and to optimize the total time required for incubation.
We characterized the performance of the digital RPA SlipChip using a serial dilution of the
MRSA gDNA stock solution at five orders of magnitude, from 1:10 dilution to 1:105
dilution. As the gDNA template was diluted, the fraction of positive wells on the RPA
SlipChip decreased proportionally after incubation (Figure 4A–E and Figure 5). No
evidence of contamination was observed as no false positives were observed in the control
(no DNA template, Figure 4F). We repeated the experiments three times at each
concentration of gDNA to test the robustness and reproducibility of the digital RPA on the
SlipChip (Figure 5). The data from digital RPA on the SlipChip with serial diluted gDNA
template followed a Poisson distribution. A statistical analysis of the results from digital
nucleic acid amplification on SlipChip was performed as previously described.22 The initial
stock concentration of MRSA gDNA was found to be approximately 10 million copies/mL
by applying Most Probable Number (MPN) Theory to fit the results from the 1:103, 1:104,
and 1:105 dilutions. The expected results (Figure 5, black line) and 95% confidence interval
(Figure 5, gray dashed lines) over the dilution range could then be calculated based on a
Poisson distribution as described previously.22.
The SlipChip design described above uses a two-step procedure for loading reagents: the
two reagents can be loaded independently of one another, an attractive capability for general
parallel processing of samples and reactions. Incubation or thermal cycling can be
performed after confining the target molecules or the first reagent into individual reaction
compartments, then additional reagents can be delivered (e.g., reagents for readout) into
each compartment in parallel. This feature also facilitates quality control during
development of new methods. Digital RPA requires this parallel processing of reactions, but
does not specifically require two-step processing. Therefore, we have also tested a
simplified device that does not have the capability to independently control reagents but
instead allows compartmentalization and mixing of the two reaction mixtures in parallel by
one-step slipping after simultaneous introduction of the reagents (Figure 6A–E). We have
tested digital RPA with a 1:104 dilution of MRSA gDNA template on this one-step
SlipChip, and the result is consistent with the two-step SlipChip (Figure 6F, compare to
Figure 7B, n≥3, p>0.2)
We have shown that RPA can be initiated at room temperature (~25 °C) after magnesium
acetate is added (Figure 1), and we have suggested that to achieve digital RPA, the reaction
mixture containing target nucleic acid template must be separated into isolated reaction
compartments before magnesium acetate is added. We tested this prediction more
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quantitatively on SlipChip: Instead of mixing Reaction Mixture 1 (without magnesium
acetate) with Reaction Mixture 2 (with magnesium acetate) on-chip, we mixed the reaction
solution (containing a 1:104 dilution of gDNA) with magnesium acetate to initiate the
reaction off-chip, and incubated the solution at room temperature (~25 °C) for 1 minute. We
refer to this off-chip mixing and incubation as the “pre-initiated” reaction solution. The pre-
initiated reaction solution was then injected into the two-step digital RPA SlipChip at room
temperature through the Type I wells, and slipped to compartmentalize. The injection step
took around 4 minutes. A second solution which contained magnesium acetate, RPA primers
and probe, and re-hydrated RPA enzyme was loaded into the Type II wells as described
above. Then, the Type I and Type II wells were overlaid by slipping the top plate relative to
the bottom plate. The SlipChip was then incubated at 39°C for 1 hour. We compared these
results to results obtained without pre-initiating the solution with magnesium acetate off-
chip (from experiments shown in Figures 4 and 5). The fraction of positive wells from the
pre-initiated sample was significantly higher than in the sample without pre-initiation
(Figure 7A, n=3, p<0.01). We attribute the large standard deviation in the measurement of
the pre-initiated sample to the variation in loading time that would change the extent of
reaction prior to compartmentalization; reaction taking place during loading is also
consistent with the “streaky” distribution of the positive wells in these experiments (see
Figure S2 in Supporting Information). These results confirm that compartmentalization
followed by chemical initiation of the RPA reaction is essential to obtain quantitative results
using digital RPA.
To further validate the performance of digital RPA on the SlipChip, we compared
experiments of digital RPA to experiments of digital PCR using the same concentration of
MRSA gDNA on the same SlipChip (1:104 dilution, see Experimental Section and Figure
S3 in Supporting Information). The same mecA gene in MRSA gDNA was targeted for
quantification in both methods. The average results from two-step digital RPA and one-step
digital RPA were not significantly different (p>0.2, n≥3) than from digital PCR (Figure 7B).
Because RPA does not benefit from the high temperature step employed in PCR, one
potential concern regarding the use of digital RPA is sensitivity to secondary structures of
nucleic acids or to contamination with nucleic-acid binding proteins; this could lead to lower
“counts” of nucleic acids. To address this concern, RPA was designed to operate in the
presence of comparatively large amounts of gp32, the single-strand binding protein from T4-
like bacteriophages. Gp32 has been reported to bind ssDNA and “melt” secondary DNA
structures.53 It has also been used as a common enhancer of various molecular biology
techniques, including PCR and reverse transcription.54 Further work will be clearly needed
to evaluate relative performance of digital PCR and digital RPA over a wide range of DNA
targets produced by different sample preparation protocols.
The digital RPA SlipChip depends on the endpoint fluorescence reading of either “0” or “1”,
unlike real-time PCR and real-time RPA25 which monitor the change of fluorescence
intensity over time. Since the enzyme activity depends on the working temperature, the
temperature dramatically affects the amplification speed in real-time RPA. Therefore, real-
time amplification methods require accurate control of temperature and careful calibration
for quantitative analysis. This may make real-time RPA less applicable in point-of-care
diagnostics in resource limited settings. Because the digital RPA SlipChip detects only the
endpoint readout instead of real-time changes of fluorescent intensity, the digital RPA
SlipChip was expected to be more tolerant to temperature fluctuations than real-time
methods. Indeed, we found that amplification of MRSA gDNA at 37°C, 39°C, and 42°C
were not significantly different (Figure 8, p > 0.2, n ≥ 4). We also found that increasing the
temperature decreases the required incubation time, and that quantitative results can be
achieved in as short as 30 min with incubation under 42°C.
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Conclusion
Here we have demonstrated that parallel initiation of pre-compartmentalized reactions on the
SlipChip lends itself to isothermal nucleic acid quantification by using recombinase
polymerase amplification (RPA) at 39 °C in a digital format. The RPA reaction will start
even at room temperature once the magnesium acetate is added into the reaction mixture,
increasing the number of false positives in digital RPA if the reaction mixture is
compartmentalized after off-chip mixing of all reagents with the nucleic acid template. The
digital RPA SlipChip addressed this issue straightforwardly by first separating the reaction
mixture containing nucleic acid template into individual compartments, in the absence of
magnesium acetate, and then delivering magnesium acetate to all compartments
simultaneously by slipping. A one-step SlipChip was also demonstrated and validated using
digital RPA, and the result was consistent with the results obtained on the two-step
SlipChip. The digital RPA SlipChip was also demonstrated to be robust in the presence of
small perturbations of incubation temperature from 37 – 42°C. The digital RPA SlipChip
was designed to contain 1550 reaction compartments of 9 nL each, with two additional sets
of wells for controls (50 wells for each control), giving a potential for detection limit of 300
copies/mL and dynamic range of 1400 to 1,000,000 copies/mL with three-fold resolution,
calculated using the method described previously.22 The RPA reaction was robust and free
of cross-contamination on the SlipChip. However, microparticles were present in the
reaction mixture even after vortexing and sonication, and additional optimization and
investigation of the RPA reaction mixture may be required to determine how the number
and size of these microparticles may affect the amplification reaction. A real-time imaging
system would validate the uniformity of the amplification rate in each positive well. No false
positive results were observed in the experiments, but the specificity of the device and
strategy for multiplex detection remain to be tested. Incorporation of a reverse-transcription
step with RPA will expand the applicability of the digital RPA SlipChip for quantitative
analysis of viral loads in resource-limited areas in developing countries. With these
developments, this methodology would provide a platform for quantification of nucleic
acids under resource limited settings and in the clinic, where digital PCR and real time PCR
may not be available due to limited infrastructure.1–11 In situations where the infrastructure
for PCR is available, the digital PCR SlipChip22 may be preferred because all the reagents
and template can be loaded as one solution. SlipChip fabricated from plastic materials52
could further lower the cost and make the device disposable to avoid potential contamination
from re-using the devices. More broadly, this methodology should find a number of
applications that require or rely on initiation of thousands of chemical reactions in parallel
using simple, solvent-resistant glass or plastic52 devices.
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Figure 1.
RPA amplification of MRSA genomic DNA (5 pg/μL) in a well plate at 25°C. Triplicate
curves (green lines) show that gDNA template was amplified at room temperature. The
control experiment without template (orange line) and the control experiment without
magnesium acetate (Mg(OAc)2, blue line) show no amplification.
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Figure 2.
Schematic drawing of the two-step SlipChip for digital RPA. A) Top plate of the SlipChip.
A zoomed in schematic drawing shows the geometry of Type I, Type II and satellite wells.
B) Bottom plate of the SlipChip. C) Assembly of top and bottom plates to establish the first
continuous fluidic path of Type I wells. D) Loading of the first reagent, Reaction Mixture 1
(red). E) Slipping breaks the first fluidic path and compartmentalizes the loaded reagent. At
the same time, the second fluidic path is formed by connecting Type II wells. The second
reagent, Reaction Mixture 2 (light blue), is loaded through a second inlet. F) A second
slipping step compartmentalizes Reaction Mixture 2 into the Type II wells and overlaps the
Type II wells with the Type I wells. The two reagents are mixed within the reaction
compartments. G) Photograph shows the entire digital RPA SlipChip next to a US quarter
for size comparison. H, I, J) Food dyes were loaded into the SlipChip to demonstrate loading
and mixing. H) Zoomed in view of Type II wells for Control 2 (no template), loaded with
blue food dye. I) Zoomed in view of reaction wells (overlapping Type I and Type II wells)
containing mixed blue and orange food dye (green). H) Zoomed in view of Type I wells for
Control 1 (no magnesium acetate), loaded with orange food dye. K,L,M,N) Experiments
with food dye demonstrate the procedures described in D, E, F.
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Figure 3.
Fluorescence microphotographs and linescans of RPA on the SlipChip before and after
incubation at 39 °C. A–B) Negative (left) and positive (right) sample wells: (A) before
incubation, the fluorescence intensity in both wells is the same. (B) After incubation, the
integrated fluorescence intensity in the positive well (right) is significantly higher compared
to the negative well (left). C–D) Control well 1, containing no magnesium acetate, before
(C) and after (D) incubation shows no significant increase in fluorescence intensity. E–F)
Control well 2, containing no gDNA template, before (E) and after (F) incubation also
shows no significant increase in fluorescence intensity.
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Figure 4.
Digital RPA on the SlipChip with different concentration of MRSA gDNA. A–E) Digital
RPA on the SlipChip with a serial dilution of target DNA template ranging from 1:10 to
1:105 of a 5 ng/μL stock solution. F) Control, no wells showed positive signal when no
target DNA was loaded.
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Figure 5.
Quantified results of digital RPA on the SlipChip. Experimental average of the number of
positive wells was plotted as a function of the dilution of the MRSA gDNA sample. Error
bars represent standard deviation of the experiment (n=3). The black solid line represents the
Poisson distribution of the calculated stock concentration from fitting the data from the
1:105, 1:104, and 1:103 dilutions of template. Gray dash lines represent the 95% confidence
interval for the fitted Poisson distribution.
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Figure 6.
SlipChip for one-step digital RPA. A–C) Schematic drawings of the SlipChip: A) Assembly
of top (solid) and bottom (dashed) plates to establish the continuous fluidic path for both
Type I wells and Type II wells. B) The first solution, Reaction Mixture 1 (red), and second
solution, Reaction Mixture 2 (blue), are introduced simultaneously into the SlipChip. C)
Slipping breaks both fluidic paths and compartmentalizes the loaded reagent. At the same
time, the Type I wells are overlaid with Type II wells to initiate the reaction. D, E)
Microphotographs showing food dyes loaded into the SlipChip to demonstrate loading and
mixing. F) Zoomed-in fluorescent image of a fraction of digital RPA on one-step SlipChip
with a 1:104 dilution of MRSA gDNA template after incubation at 39°C.
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Figure 7.
A) Comparing on-chip mixing (no pre-initiation) to pre-initiation with magnesium acetate
on the two-step digital RPA SlipChip. The sample with pre-initiation with magnesium
acetate prior to compartmentalization shows a higher fraction of positive wells, indicating
that compartmentalization prior to the addition of magnesium acetate is crucial to achieve
accurate digital RPA. B) Comparing two-step digital RPA, one-step digital RPA and digital
PCR. Samples containing MRSA gDNA at the same dilution (1:104) were quantified using
two-step digital RPA (as in Figure 4) (left, n=3), one-step digital RPA (as in Figure 6)
(middle, n=5), and digital PCR (right, n=3) on the RPA SlipChip. Error bars represent
standard deviation.
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Figure 8.
RPA two-step SlipChip for amplification of MRSA gDNA with incubation at different
temperatures. A–C) Representative fluorescent images of RPA for MRSA gDNA with
dilution of 1:104 at 37°C (A), 39°C (B), and 42°C (C). D) Histogram showing number of
positive wells from RPA on the SlipChip at different incubation temperatures. Error bars
represent standard deviation of the experiment (p > 0.2, n ≥ 4).
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